MALAT1 and breast cancer: Recent studies revealed a great variety of lncRNA (e.g., NEAT1, MALAT1, CCAT2, and FOXM1) and miRNA (e.g., miR-3662, miR-23b-3p, miRNA328, and miR-429) [3,94,95,96,97,98] that promote cell proliferation, angiogenesis, metastasis, and chemo- and immune-resistance in different types of cancers, such as lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), BC, HCC, NSCLC, glioma, and acute myeloid leukemia.